Wave Life Sciences is trading 5.45% up now at $5.32 after falling 16.89% to $5.04 during the August 11 regular session.

  • Management presented at the Bank of America SMID Cap Virtual Conference on August 11, highlighting WVE-007, WVE-006, and WVE-008.
  • No reliable source directly attributes the after-hours rebound to the presentation.
  • Recent pressure followed a Q2 revenue miss and wider loss, with revenue of $2.3 million versus $7.65 million expected.